Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia

Autor: Rikke Bech Nielsen, Jane Baumgartner-Nielsen, Niels Anker Peterslund, Torben Steiniche, Bang, K., Mette Søndergaard Deleuran, Amore, Francesco Annibale D.

Publikováno v: Nielsen, R B, Baumgartner-Nielsen, J, Peterslund, N A, Steiniche, T, Bang, K, Deleuran, M & D'Amore, F A 2013, ' Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia ', British Journal of Dermatology, vol. 169, no. 2, pp. 469-472 .
Aarhus University

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2b6068ca0b13b7d5de263d9c0aa4cdf4
https://pure.au.dk/portal/da/publications/alemtuzumab-alz-is-an-effective-treatment-for-both-primary-and-relapsed-severe-paraneoplastic-pemphigus-pnp-associated-to-bcell-chronic-lymphocytic-leukemia(741f7ca8-468c-4aae-b1fa-8778e9ab33ac).html